Monsanto research now offers EXZACT genome-editing tech

· October 3, 2016

A non-exclusive global option and licensing agreement between Monsanto and Dow AgroSciences hopes to put the next generation of crop improvements into farmers’ hands. Dow AgroSciences’ EXZACT Precision Technology Platform for research and commercial development of new crop solutions will now be available across Monsanto Company’s research portfolio. EXZACT technology, which Dow AgroSciences has developed […]

Load more